<?xml version="1.0" encoding="UTF-8"?>
<p>To date, no SARS-CoV-2-specific antiviral drugs or vaccines have been described for COVID-19. Therefore, a safe and stable vaccine for COVID-19 is urgently needed, and it is expected to be ready within 18Â months [
 <xref rid="B81" ref-type="bibr">81</xref>]. Vaccines specific for SARS-CoV-2 will immunize people worldwide in the future. It is hoped that drugs specifically targeted for COVID-19 also will be widely developed. Meanwhile, the origin, intermediate host, structure and pathogenesis of SARS-CoV-2 will be the focus of future research. Moreover, prediction of whether the similar coronaviruses can infect humans will be import for all the world. We hope that vaccines specific for the similar coronaviruses will be developed in advance to prevent epidemics in the world.
</p>
